About Aparna Laboratories Private Limited
Data last updated:
Aparna Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24297TG2020PTC142017.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Sannareddy Aparna Reddy and Aswin Reddy Pochana.
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 802 D.No 6 – 3 – 352/2 Road No1 Banjara Hills, Hyderabad, Telangana, India – 500034.
For more details, the company can be reached via its website aparnaconstructions.com.
Company details
Contact details
Aparna Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is aparnaconstructions.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address802 D.No 6 – 3 – 352/2 Road No1 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aparna Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aparna Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Aparna Laboratories Private Limited
FY 2025 filings availableAparna Laboratories Private Limited reported revenue of ₹1,023 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aparna Laboratories Private Limited, buy the company report.
Board of directors of Aparna Laboratories Private Limited
Aparna Laboratories has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sannareddy Aparna Reddy Also directs: Aparna Transportation Services LLP, Aparna Mines & Minerals Private Limited, Aparna Chemicals Private Limited and 5 more | Director | 22 Jul 2020 | 6 Years 3 Months | Current |
| Aswin Reddy Pochana Also directs: Aparna Mines & Minerals Private Limited, Aparna Chemicals Private Limited, Aparna Pharmaceuticals Private Limited and 5 more | Director | 22 Jul 2020 | 6 Years 3 Months | Current |
| Rakesh Reddy Chennuru | Director | 22 Jul 2020 | 6 Years 3 Months | Current |
Auditor
Aparna Laboratories Private Limited is audited by Lalith Prasad and Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Lalith Prasad and Co | FY 2023 | 08089S |
Shareholding
The shareholding of Aparna Laboratories Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aparna Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aparna Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aparna Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aparna Laboratories Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
GST
No GST registration is on our record for Aparna Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aparna Laboratories Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Aswin Reddy Pochana was appointed as Director on 22 Jul 2020.
News
Frequently asked questions
Aparna Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 July 2020 (6+ years old) and is registered under CIN U24297TG2020PTC142017.
Aparna Laboratories has 3 current directors:
- Sannareddy Aparna Reddy - Director
- Aswin Reddy Pochana - Director
- Rakesh Reddy Chennuru - Director
The latest financial statements of Aparna Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Aparna Laboratories is U24297TG2020PTC142017. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aparna Laboratories was incorporated on 22 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Aswin Reddy Pochana was appointed as Director on 22 Jul 2020. Rakesh Reddy Chennuru was appointed as Director on 22 Jul 2020. Sannareddy Aparna Reddy was appointed as Director on 22 Jul 2020.
Aparna Laboratories can be reached through the website aparnaconstructions.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Aparna Laboratories is at 802 D.No 6 – 3 – 3522 Road No1 Banjara Hills, Hyderabad, Telangana, India – 500034.
Aparna Laboratories operates in the pharma industry, in the drug formulation and development segment.
Aparna Laboratories is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
